| Followers | 52 |
| Posts | 14191 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Sunday, February 01, 2026 12:40:10 PM
This is important .
UNCY needs to present at any and every major Renal conference they can between now and June 29th .
Theres a story I have about approval of a serum potassium drug ..Veltassa ...which in brief ....I owned Co RLYP , Valtessa was approved but wife wasn't prescribing it . I asked why not ...her answer " Head of Dept hasn't OK'd it "
Head of Dept goes to conference ...does a big deep dive into Veltessa with RLYP chief medical officer ...comes back as says ..."OK start prescribing it "
It was like a light was switched on
Ok so here is the question related to the quote. UNCY needs to present at any and every Renal conference between now and June 29th. Why? Because June 29th is when they expect to be granted approval for OLC. Now, last year at this time UNCY was expecting approval of OLC before the dreaded CRL came out. So my question is (in order to figure out whether this year they will carry out your edict that they should present everywhere) did UNCY present to every Renal conference LAST year while expecting OLC approval but before they got the CRL? If they did not do this last year, what confidence do we have that they will do so now? AND why is it in so many companies, that posters (like yourself and others) know more how to operate the business than these moocher managements?
Recent UNCY News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 06:15:05 PM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
- Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY • PR Newswire (US) • 10/02/2025 12:04:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc.(UNCY) Shareholders • PR Newswire (US) • 09/29/2025 12:45:00 PM
- Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY • Business Wire • 09/25/2025 07:19:00 PM
- The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 09/25/2025 12:45:00 PM
- Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 09/22/2025 12:45:00 PM
- Shareholders of Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights - UNCY • PR Newswire (US) • 09/18/2025 12:45:00 PM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
